Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer.

Journal of cellular and molecular medicine - 1 Sept 2023

Wen Yu-Ching, Lin Chia-Yen, Hsiao Chi-Hao, Wang Shian-Shiang, Huang Hsiang-Ching, Lin Yung-Wei, Ho Kuo-Hao, Chang Lun-Ching, Yang Shun-Fa, Chien Ming-Hsien

Abstract excerpt

CD26/dipeptidyl peptidase IV (DPP4) is a multifunctional cell-surface glycoprotein widely found in many cell types, and a soluble form is present in body fluids. There is longstanding evidence indicating a tumour-promoting or -suppressive role of DPP4 in different cancer types. However, studies focusing on the impacts of genetic variants of DPP4 on cancers are very rare. Herein, we conducted a case-control study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Dipeptidyl Peptidase 4

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 37533175
DOI: 10.1111/jcmm.17845
PMCID: PMC10468658

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer.PMID 37533175Read ↗

DPP4 genetic variants influence baseline prostate-specific antigen levels: the J-MICC study.Semantic proximity Read ↗

Pyroptosis-Related Genetic Variants and Protein Levels Determination in Prostate CancerSemantic proximity Read ↗

Dipeptidyl peptidase-IV and related molecules: markers of malignancy?Semantic proximity Read ↗

Single nucleotide polymorphisms in DKK3 gene are associated with prostate cancer risk and progression.Semantic proximity Read ↗

PADI4 has genetic susceptibility to gastric carcinoma and upregulates CXCR2, KRT14 and TNF-α expression levels.Semantic proximity Read ↗

Association of the rs1042522 polymorphism with increased risk of prostate adenocarcinoma in the Pakistani population and its HuGE review.Semantic proximity Read ↗

Toll-like receptor 4 genetic variation and advanced prostate cancer risk.Semantic proximity Read ↗

Association of dipeptidyl peptidase IV polymorphism with clinicopathological characters of oral cancer.Semantic proximity Read ↗

Proteomic Characterization of Primary and Metastatic Prostate Cancer Reveals Reduced Proteinase Activity in Aggressive TumorsSemantic proximity Read ↗

CD24 is a genetic modifier for risk and progression of prostate cancer.Semantic proximity Read ↗

Programmed death-1 polymorphisms is associated with risk of esophagogastric junction adenocarcinoma in the Chinese Han population: A case-control study involving 2,740 subjects.Semantic proximity Read ↗

Associations of CYLD, JAK2 and TLR4 Genotypes with PSA Levels and Immunophenotype in Benign Prostatic Hyperplasia and Prostate Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.